Abstract:On the basis of the structures and activities of our previously identified non-nucleoside reverse transcriptase inhibitors (NNRTIs), we designed and synthesized two sets of derivatives, diarylpyridines (A) and diarylanilines (B), and tested their anti-HIV-1 activity against infection by HIV-1 NL4-3 and IIIB in TZM-bl and MT-2 cells, respectively. The results showed that most compounds exhibited potent anti-HIV-1 activity with low nanomolar EC50 values, and some of them, such as 13m, 14c, and 14e, displayed high potency with subnanomolar EC50 values, which were more potent than etravirine (TMC125, 1) in the same assays. Notably, these compounds were also highly effective against infection by multi-RTI-resistant strains, suggesting a high potential to further develop these compounds as a novel class of NNRTIs with improved antiviral efficacy and resistance profile.

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of 2‐(4‐(naphthalen‐2‐yl)‐1,2,3‐thiadiazol‐5‐ylthio)‐n‐acetamides As Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 13

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of Novel 2,4‐disubstituted 7‐Methyl‐1,1,3‐trioxo‐2,4‐dihydro‐pyrazolo[4,5‐e][1,2]thiadiazines.

ChemInform Abstract: Design, Synthesis and Anti‐hiv Integrase Evaluation of 1,2,3‐triazol‐4‐yl‐substituted 1,4‐dihydro‐4‐oxo‐1,5‐naphthyridine‐3‐carboxylic Acids.

ChemInform Abstract: Anti Human Immunodeficieny Virus‐1 (HIV‐1) Agents. Part 1. Discovery of Benzyl Phenyl Ethers As New HIV‐1 Inhibitors in Vitro.

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

ChemInform Abstract: Anti-Human Immunodeficiency Virus-1 (HIV-1) Agents. Part 3. Synthesis and in Vitro Anti-Hiv-1 Activity of Some N-Arylsulfonylindoles.

ChemInform Abstract: Synthesis and Evaluation of A‐seco Type Triterpenoids for Anti‐hiv‐1 Protease Activity.

Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines As Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

HIV‐1 Intergrase Inhibitors: 2003—2004 Update

Non-nucleoside Reverse Transcriptase Inhibitors (part 18): Synthesis and Anti-Hiv Activity of 4-Allylamino or 4-Azido Substituted Diaryltriazines.

Nonnucleoside HIV‐1 Reverse‐Transcriptase Inhibitors. Part 5. Synthesis and Anti‐hiv‐1 Activity of Novel 6‐naphthylthio HEPT Analogues.

ChemInform Abstract: N‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea and N′‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐chloropyridyl)]‐thiourea As Potent Inhibitors of Multidrug‐Resistant Human Immunodeficiency Virus‐1.

Design, Synthesis, and Biological Evaluations of Novel Quinolones As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors.

Regioselective Synthesis of the Novel N4‐Substituted Pyrazolo[4,5‐e][1,2,4]thiadiazines As Potent HIV‐1 NNRTIs.

Discovery of Diarylpyridine Derivatives As Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Synthesis of 1‐(alkoxymethyl)‐5‐benzyl‐6‐methyluracil As Potential Nonnucleoside HIV‐1 RT Inhibitors.